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Abstract
Background: Bone marrow (BM) blast count is an essential parameter for classification and prognosis of
myelodysplastic syndromes (MDS). However, a high degree of cell atypias in bone marrow hemopoietic cells may
be found in this group of clonal disorders, making it difficult to quantify precisely myeloblasts, and to distinguish
them from promyelocytes and atypical immature myeloid precursors. Our aim was to investigate whether
computerized image analysis of routine cytology would help to characterize these cells.
Methods: In May-Grünwald-Giemsa stained BM smears of 30 newly diagnosed MDS patients and 19 cases of
normal BM, nuclei of blasts and promyelocytes were digitalized and interactively segmented. The morphological
classification of the cells was done by consensus of two observers. Immature granulocytic precursors, which could
not be clearly classified either as blasts or promyelocytes, were called “atypic myeloid precursors”. Nuclear
morphometry and texture features derived from the co-occurrence matrix and fractal dimension (FD) were
calculated.
Results: In normal BM, when compared to myeloblasts, nuclei of promyelocytes showed significant increase in
perimeter and local texture homogeneity and a decrease in form factor, chromatin gray levels, Haralick’s entropy,
inertia, energy, contrast, diagonal moment, cluster prominence, the fractal dimension according to Minkowski and
its goodness-of-fit. Compared to normal myeloblast nuclei, the chromatin texture of MDS myeloblasts revealed
higher local homogeneity and goodness-of-fit of the FD, but lower values of entropy, contrast, diagonal moment,
and fractal dimension. The same differences were found between nuclei of normal promyelocytes and those of
MDS. Nuclei of atypical myeloid precursors showed intermediate characteristics between those of blasts and
promyelocytes according to the quantitative features (perimeter, form factor, gray level and its standard deviation),
but were similar to promyelocytes according to the texture variables inertia, energy, contrast, diagonal moment,
cluster prominence, and Minkowski’s fractal dimension.
Conclusion: BM atypical immature myeloid precursors are difficult to be correctly classified in routine cytology.
Although their cytoplasm is more similar to that of myeloblasts, computerized texture analysis indicates a nuclear
chromatin remodeling more close to the promyelocyte, thus indicating an asynchronous intermediate maturation
stage between blast and promyelocyte.
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Myelodysplastic syndromes (MDS) are a group of hemo-
poietic clonal disorders characterized by peripheral blood
cytopenias and a cellular bone marrow (BM) showing cell
atypias that reflect abnormalities in proliferation, matura-
tion and apoptosis of hemopoietic precursors [1-6].
According to WHO criteria [7-9] the percentage of blasts
counted in BM cytology is an essential parameter for
diagnosis and classification of the several types of MDS,
as well as for the differential diagnosis between refractory
anemia with excess of blasts (RAEB) and acute myeloid
leukemia. In normal hemopoiesis, strict morphological
criteria can easily be used to define each stage of cell
maturation, but in MDS, immature cells presenting an
asynchronous maturation may often be difficult to clas-
sify [4,6-9]. Standardized morphologic criteria have been
recommended [8,9] in order to separate MDS blasts and
MDS promyelocytes. Yet, there is always some degree of
subjectivity, although the FAB Group [1] and the Interna-
tional Working Group on MDS [8,9] had defined classifi-
cation criteria, which were also included in the 2008
WHO classification [7]. Moreover, the European Leuke-
miaNet published in the Internet a consensus-based cell
library elaborated by experienced morphologists [8,9]
that could be used as a guide for daily work and training.
Despite of these efforts, the morphologic diagnosis con-
tinues to be a difficult task, and the morphologic diagno-
sis of MDS should only be done by a consensus of two
expert morphologists [3,6].
In cytological bone marrow smears of MDS patients,
some immature cells may not be classifiable in a satisfac-
tory way, because they show simultaneously characteristics
of blasts and promyelocytes, thus not fulfilling the criteria
of either category. This problem is known to the practicing
hematologist, but, surprisingly not discussed in the scienti-
fic literature.
In recent years, virtual microscopy and computerized
image analysis gained increasing importance [10-14].
These techniques have been widely used in pathology
and cytology for the differentiation of normal cells,
benign and malignant tumors [15-17], as prognostic mar-
kers in malignancy [18-20] and in order to examine chro-
matin remodeling of cells in culture after incubation with
carcinogens [21], hormones [22] and therapeutic agents
[23,24]. Computerized image analysis has shown to be a
fast and reliable way for quantitative morphologic analy-
sis [10,18,19,25-28], and moreover, to be a possibility to
detect subtle morphologic changes which cannot be
recognized by conventional microscopy even by an
expert.
The aim of the present study was to examine whether
computerized nuclear texture analysis could help to
characterize in a more objective way the blasts and
promyelocytes in normal bone marrow, as well as in
patients with MDS. We also wanted to examine if this
technology was able to classify atypical immature mye-




Routinely May-Grünwald-Giemsa-stained bone marrow
(BM) slides from 19 morphologically normal bone mar-
rows and from 30 consecutive cases of MDS were used for
this analysis. Morphologically normal BM smears (control
group) were obtained from the diagnostic work-up of
patients with idiopathic thrombocytopenic purpura, with
hypersplenism, and non-Hodgkin’sl y m p h o m aw i t h o u t
bone marrow involvement. The diagnosis of MDS was
based on the presence of sustained peripheral (PB) cytope-
nias, cell atypias in BM cytology and BM cytogenetics
according to WHO 2008 criteria [7-9].
This project was approved by the Ethic’sC o m i t e eo f
our Institution (Proc 0652.0.146.000-08).
Image analysis
At least 30 consecutive nuclei of each type of immature
granulocytic precursors (myeloblasts and promyelocytes)
per patient were analyzed. Cells were classified by two
independent experts (JRV and ILM) according to the cri-
teria of the European Leukemianet Project [9] (Figure 1).
We considered as “atypical immature myeloid precursors”
(Figure 1C) cells without cytoplasmic Golgi apparatus, but
with nuclear characteristics resembling more mature cells
than myeloblasts, and that did not fulfill the proposed
criteria for classification [8,9].
Cell images were captured by a Leica DC 500 digital sys-
tem (bmp-format; sample spacing of 0.1 μm/pixel, 1.25
numerical aperture, 100x oil immersion objective). The
nuclear images were interactively segmented, converted to
grayscale format with gray levels ranging between 0 and
255 (being 255 the brightest). We examined variables of
geometric morphometry such as nuclear area, form factor,
mean gray level, and standard deviation of gray values.
We also calculated texture features derived from the co-
occurrence matrix [17,27,28] and the fractal dimension
(FD) according to Minkowski-Bouligand after pseudo-3D




We compared the values obtained for normal myeloblasts
and promyelocytes for all nuclear morphometric and tex-
ture features using the t-test for paired values. Student’s
t-test was used to compare morphometric and texture
features of normal and MDS blasts and of normal and
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between features of blasts, promyelocytes and atypical
myeloid precursors of MDS patients were calculated by
analysis of variance for repeated measures. Differences
between blast and atypical myeloid precursors or
between the latter and promyelocytes were calculated
with the help of t-tests for paired values.
For every nuclear morphometric or texture feature we
tried to find out whether the values of the atypical mye-
loid precursors were more similar to those of MDS-blasts
(no significant difference between atypical precursors and
blasts, but between atypical precursors and promyelo-
cytes), or MDS-promyelocytes (significant difference
between blasts and atypical precursors but no significant
difference between atypical precursors and promyelo-
cytes). A nuclear characteristic was considered to be
“intermediate” between MDS-blasts and MDS-promyelo-
cytes, when significant differences were found both
between MDS-blasts and atypical precursors and
between atypical precursors and MDS-promyelocytes. A
variable was called “not defined”, when the global test or
both dependent t-tests were not significant (p > 0.05).
Results
Diagnostic smears from 19 normal BM and 30 cases of
MDS were examined. Median age of the patients with
normal BM was 57 years (24 - 85; 9 males and 10
females). The median age of the MDS patients was 64
years (30 - 85). There were 16 males and 14 females
(Table 1). According to the WHO type, most cases were
RCMD (refractory cytopenia with multilineage dysplasia)
and RAEB (refractory anemia with excess of blasts).
In normal BM, nuclei of promyelocytes showed signifi-
cant changes, such as an increase of perimeter and local
texture homogeneity and a decrease in form factor, chro-
matin gray levels, Haralick’s entropy, inertia, energy, con-
trast, diagonal moment, cluster prominence, Minkowski’s
fractal dimension and its goodness-of-fit when compared
with that of normal blasts (Table 2).
Compared to normal myeloblast nuclei, chromatin
texture of MDS blasts had a higher local homogeneity
as well as goodness-of-fit of the fractal dimension, but a
lower entropy, contrast, diagonal moment, and fractal
dimension (Table 3). Nuclei of promyelocytes from
MDS showed a larger nuclear area, local homogeneity
and goodness-of-fit of FD, but lower inertia, entropy,
energy, contrast, diagonal moment and FD than normal
ones (Table 4).
The values obtained for nuclei of granulocytic precur-
sors in MDS are presented in Table 5.
Nuclei of atypical myeloid precursors showed inter-
mediate characteristics between those of blasts and pro-
myelocytes according to the quantitative features
perimeter, form factor, gray level and its standard devia-
tion, but were similar to promyelocytes according to the
texture variables inertia, energy, contrast, diagonal
moment, cluster prominence and Minkowski’sf r a c t a l
dimension. None of the features studied showed close-
ness to myeloblasts. These findings were independent of
the WHO type of MDS.
Discussion
In recent years, computerized image analysis has been
widely used in histology and cytology in order to exam-
ine tissue differentiation, for tumor classification
Figure 1 Immature granulocytic precursors observed in the MDS cases. A: myeloblast. B: promyelocyte. C: atypical immature granulocytic
precursor. May-Grünwald-Giemsa ×1000.
Table 1 Age and hematological data of the MDS cases
(median)
WHO type RA/RARS* RCMD** RAEB***
Number of cases 4 15 11
Age (years) 64 64 62
Hemoglobin (g/dL) 10.5 10.3 8.1
PB leukocytes (×10
3/mm
3) 4.7 3.6 3.1
PB platelets (×10
3/mm
3) 234 240 184
BM Blasts % 2.0 1.0 8.0
* RA/RARS = refractory anemia/sideroblastic anemia; ** RCMD = refractory
cytopenia with multilineage dysplasia; *** RAEB = refractory anemia with
excess of blasts
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ables in neoplasias [18-20]. This approach has also been
used in basic research for analyzing nuclear texture
changes that reflect chromatin remodeling of cells after
incubation with carcinogens [21], hormones [22] and
therapeutic agents [23,24].
Chromatin remodeling, which is primarily due to epi-
genetic events, can be found during cell differentiation or
malignant transformation [20,21,23,24,26]. In normal
hemopoiesis, gene expression during normal cell matura-
tion is controlled by genetic and epigenetic changes [30].
Blast cells in acute myeloid leukemia and MDS always
present epigenetic abnormalities and their DNA methyla-
tion signature is different to that of any stage of normal
myeloid maturation, an observation which permits to dis-
tinguish normal and leukemic blasts [30-33].
In the present study we examined the utility of compu-
terized chromatin texture analysis for the diagnosis of
normal and atypical immature myeloid precursors in
routine BM smears. In normal BM, all except three of
the quantitative features examined, presented significant
differences between blasts and promyelocytes. Thus,
chromatin texture analysis in routine BM cytology is able
to define cells in early stages of myeloid maturation.
In MDS, genetic and epigenetic alterations provoke
abnormalities of proliferation, maturation, and apoptosis
[5,6,32-34], which, of course, are reflected in subtle altera-
tions of the chromatin structure. The expression of various
lineage and maturation-related membrane proteins may be
discordant in granulopoietic precursors [32-34] provoking
also morphological atypias. All these alterations hamper
the cell classification. The difficulties in classify several
cases with MDS are well known. The European Leukemia-
Net created a consensus-based cell library elaborated by
experienced morphologists and downloaded it in the
Internet [9]. Its purpose is to be a guide for daily work and
training. Furthermore, it is still recommended that the
morphologic diagnosis of MDS should be achieved by a
consensus of two experienced morphologists [3,6]. Our
study underlines these problems of classification. The cells
diagnosed as atypical immature myeloid precursors in the
present study did not - on light microscopic examination -
reveal a Golgi apparatus, and would be therefore morpho-
logically classified as blasts. However, the nucleus showed
features more close to that of promyelocytes or nuclei of
an “intermediate” state between blasts and promyelocytes.
Computerized texture analysis confirmed this subjec-
tive impression, since 4 features presented intermediate
values between blasts and promyelocytes and 6 variables
pointed out a similarity with nuclei of promyelocytes.
Although the cytoplasm in these atypical cells still reveals
characteristics of a blast, the nuclear structure is more
similar to a promyelocyte, thus indicating an asynchro-
nous maturation in MDS patients.
The existence of this intermediate maturation stage is
of clinical importance. Cytologists basing their diagnosis
mainly on cytoplasmic criteria will count these atypical
immature cells together with blasts and thus increase the
blast count. Other observers, emphasizing the similarity




2 111.9 112.7 0.75
Perimeter 579 636 <0.0001
Form factor 0.957 0.792 <0.0001
Mean gray level 129.3 120.8 <0.0001
SD gray level* 8.6 8.1 0.04
Haralick’s entropy 7.90 7.77 0.02
Inertia 4.17 3.82 <0.0001
Local homogeneity 0.535 0.538 0.51
Energy 7177 6430 <0.0001
Contrast 4.17 3.82 0.005
Diagonal Moment 19.1 17.7 <0.0001
Cluster prominence 3.38 2.79 0.01
FD** Minkowski 2.134 2.128 0.08
R
2 *** 0.99647 0.99613 0.007
* SD = standard deviation; ** FD = fractal dimension, ***R
2 goodness-of-fit of
the fractal dimension.
Table 3 Mean values of the variables that differed in
normal myeloblasts and those of MDS
Normal MDS p
Haralick’s entropy 7.90 7.65 0.01
Inertia 4.17 3.67 0.05
Local homogeneity 0.535 0.553 0.01
Energy 7177 6749 n.s
Contrast 4.17 3.67 0.05
Diagonal moment 19.1 17.4 0.05
FD Minkowski * 2.134 2.122 0.01
R
2** 0.99647 0.99819 <0.005
* FD = fractal dimension. **R
2 goodness-of-fit of the fractal dimension.
Table 4 Mean values of the variables that differed in
normal promyelocytes and those of MDS
Normal MDS p
Haralick’s entropy 7.77 7.52 0.03
Inertia 3.82 3.28 0.01
Local homogeneity 0.538 0.558 0.01
Energy 6430 5595 0.04
Contrast 3.82 3.28 0.01
Diagonal moment 17.7 15.6 0.02
FD Minkowski * 2.128 2.118 0.03
R
2 ** 0.99613 0.99809 0.001
* FD = fractal dimension. **R
2 goodness-of-fit of the fractal dimension.
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promyelocytes, or count them separately, thus diminish-
ing the blast count. This may imply in a different classifi-
cation for the patient.
The BM blast count is considered very important for the
classification of MDS in the revised WHO classification
[7] as well as for the determination of the IPSS and WPSS
scores [2,31,32]. Furthermore, the blast count is consid-
ered to be an independent prognostic feature of utmost
importance in MDS [2,6,7,33,35-37]. Therefore, additional
pathophysiological and molecular studies should be per-
formed in order to investigate whether these atypical pre-
cursor cells should not be counted as blasts, as suggested
by our investigation.
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